Acuvi AB

Acuvi AB

SSTO:ACUVI
5.81
SEK
-0.06
(-1.02%)
-0.60EPS
367.57MMarket Cap
Feb 25Next Earn
Acuvi AB
STO:ACUVI
(Nasdaq Stockholm)

Recent

price

5.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
SEK
0.97
1.53
1.44
1.78
1.85
2.11
1.81
2.77
7.4
7.46
6.38
6.43
6.4
Revenue per Share
-2.08
-4.15
-2.63
-1.1
-1.5
-1.09
-1.59
-2.58
-3.85
0.25
1.04
-0.48
-0.6
Basic EPS, GAAP
-1.83
-3.37
-2.29
-0.61
-1.88
-2.4
-1.51
-1.71
-0.94
0.48
-0.34
-0.6
0.56
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1.01
1.12
2.06
0.79
4.32
3.28
3.13
15.81
13.56
13.71
14.76
12.43
12.46
Book Value per Share
-0.42
0.09
1.28
0.64
4.06
2.61
2.27
-1.34
-1.57
-0.63
0.86
1.76
1.68
Tangible Book Value per Share
12
8
10
14
14
15
15
19
25
26
28
32
32
Basic Weighted Avg Shares
12
12
15
25
26
31
27
51
185
191
176
204
203
Sales/Revenue/Turnover
-229.3
-235.57
-178.37
-60.53
-80.02
-51.37
-87.51
-91.21
-62.61
9.47
10.2
-2.07
-5.79
Operating Margin (%)
- -
5
4
9
1
1
1
22
98
21
12
26
33
Depreciation Expense
-25
-33
-28
-15
-21
-16
-24
-48
-96
6
29
-15
-19
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-214.78
-271.2
-183.49
-61.68
-81.19
-51.83
-87.93
-93.03
-52.1
3.41
16.3
-7.52
-9.35
Profit Margin (%)
-2
4
20
10
60
34
29
10
38
22
29
71
70
Working Capital
8
6
7
6
4
1
- -
8
31
51
35
45
42
LT Debt
12
14
25
10
63
48
49
386
341
354
435
415
416
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-250.56
-141.97
-88.69
-58.06
-28.75
-49.94
-22.01
-26.5
1.87
7.27
-3.61
-4.47
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
ST Debt
38
14
20
LT Borrowings
20
27
25
LT Finance Leases
18
18
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
33
33
33
Market Capitalization
653
576
368

Working Capital

SEK

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
Total Current Assets
120
121
124
Cash, Cash Equivalents & STI
9
17
24
Accounts Receivable, Net
36
34
28
Inventories
56
65
66
Total Current Liabilities
84
50
54
Payables & Accruals
- -
- -
- -
ST Debt
38
14
20
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
125.38%
140.77%
-4.77%
Free Cash Flow
-7.72%
-41.67%
106.89%
Net Income, GAAP
28.51%
56.22%
-153.53%
Sales/Revenue/Turnover
46.19%
71.8%
16.1%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
45
43
44
43
176
2025
51
47
- -
54
204
2026
51
- -
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.2
- -
-0.15
0.71
1.04
2025
0.12
0.22
- -
-0.61
-0.48
2026
-0.27
- -
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Acuvi AB is a Sweden-based technology company that develops, manufactures, and markets high-precision motion systems, miniature motors, and micropositioning solutions for mission-critical industrial, scientific, and medical applications. Founded in 1997 and headquartered in Uppsala, Sweden, the company operates through three principal subsidiaries and operating brands: PiezoMotor, Sensapex, and TPA Motion. Acuvi caters to original equipment manufacturers, academic institutions, and research laboratories across specialized sectors, including medical technology, life science research, semiconductor manufacturing, aerospace, defense, and high-end industrial automation. The company offers a comprehensive portfolio of motion control components, sub-assemblies, and integrated systems organized by operating entity: proprietary piezoelectric direct-drive motors and compact linear actuators utilizing patented Piezo LEGS technology; non-magnetic and ultra-high vacuum-compatible linear and rotary motors; precision linear, rotary, and goniometric positioning stages; electronic drive controllers and amplifiers under the PiezoMotor brand; high-precision life science research instrumentation, including uMp series micromanipulators for drift-free cellular positioning, uMs motorized microscope workstations, uMc automated pressure control systems, and proprietary uMx control software and software development kit automation platforms under the Sensapex brand; and custom-engineered multi-axis positioning systems, linear actuators, precision mechanical stages, custom sub-assemblies, and original equipment manufacturer integration services under the TPA Motion brand. Acuvi operates engineering, manufacturing, and support facilities in Uppsala, Sweden; Oulu, Finland; and Fort Mill, South Carolina, United States, serving a global customer base across Europe, North America, and the Asia-Pacific region. In recent developments, the company reorganized and completed a corporate rebranding from PiezoMotor Uppsala AB to Acuvi AB to unify its operating entities under a single precision motion platform. To optimize operating profitability and focus resources on core proprietary technologies, Acuvi announced the discontinuation of a legacy third-party medical technology distribution agreement in 2026. In August 2026, the company entered an exclusive global commercial partnership with a Japanese manufacturer to introduce a new product line of motorized precision stages under the PiezoMotor brand. Furthermore, Acuvi appointed Jens Lagergren as Chief Financial Officer in June 2026 and expanded its commercial penetration across high-barrier applications, including semiconductor production equipment, Formula 1 racing applications, and United States defense contracts.